From 576d07ab75b4471d79142b87eb8b93d24320305a Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Thu, 21 Mar 2024 15:01:01 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/STOP2030___Web___Posts.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/pages/STOP2030___Web___Posts.md b/pages/STOP2030___Web___Posts.md index 52f11dd4..615e78f3 100644 --- a/pages/STOP2030___Web___Posts.md +++ b/pages/STOP2030___Web___Posts.md @@ -1,7 +1,7 @@ # [[WHO]] visit - - # REALISE study registration - - ## The design of our REALISE study is published + - ## The design of our REALISE study is complete, and published - #+BEGIN_VERSE At STOP2030 we want to provide a pharmacological tool that helps at delivering WHO's elimination goals for soil-transmitted helminthiasis (STH). That is why we're happy to announce that we've completed the design of the REALISE study (Real world Evaluation of an ALbendazol-Ivermectin coformulation Safety and Effectiveness). The details of the trial have been published in clinicaltrials.gov and the Pan African Clinical Trial Registry, and are now ready to be delivered to the Institutional Review Boards (IRBs) in Ghana and Kenya, the two countries were it will be carried out.